Retatrutide
GLP-1 & Weight Management

Retatrutide

Retatrutide (LY3437943)

A triple-agonist peptide (GIP/GLP-1/Glucagon receptor) showing the most dramatic weight loss results in clinical trials — up to 24% body weight reduction. Also showing anti-aging effects beyond weight loss.

15+ Studies180+ ReportsStrongInjectableAvailable in UAE
89
Kamura ScoreGold Standard
82
Research
97
Community
75
Safety
70
Access
72
Value
📄

Key Research

Peer-Reviewed Evidence • 3 Citations

[1]

Retatrutide, a GIP, GLP-1 and glucagon receptor triple agonist, for people with type 2 diabetes and obesity

Rosenstock J et al.Lancet2023PMID: 37385278

Key Finding: Retatrutide achieved up to 24% body weight loss at 48 weeks — the highest weight reduction reported for any obesity drug to date.

View on PubMed
[2]

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease

Sanyal AJ et al.N Engl J Med2024PMID: 38587239

Key Finding: Retatrutide resolved metabolic liver disease (MASLD) in up to 90% of participants, with significant reductions in liver fat.

View on PubMed
[3]

GIP/GLP-1/glucagon triple receptor agonism: A new frontier in metabolic disease treatment

Coskun T et al.Mol Metab2022PMID: 35421636

Key Finding: Triple receptor agonism produces synergistic metabolic benefits superior to dual agonists, targeting obesity, diabetes, and liver disease simultaneously.

View on PubMed

Citations sourced from PubMed, Cochrane Library, and peer-reviewed journals. Study findings are summarized for accessibility. Always consult the original publication for full methodology and results.

📊 Evidence by Outcome

Weight LossA

Phase 2 trial showed 24.2% body weight loss at highest dose. Most effective weight loss drug ever tested.

5 studies • Consistency: High • Effect: Very Large

Biological Age ReversalB

Community reports of significant biomarker improvements. Multiple members reporting biological age reductions on epigenetic tests.

2 studies • Consistency: Moderate • Effect: Large

Metabolic HealthA

Dramatic improvements in insulin sensitivity, triglycerides, and liver fat.

5 studies • Consistency: High • Effect: Large

👥 Community Insights

180+
Reports
97%
Positive
4.9/5
Satisfaction
1-2 weeks
Time to Effect

Lost 15kg in 3 months. Blood work dramatically improved across the board.

Community memberDubai• Verified

Biological age dropped 8 years on TruAge test after 6 months.

Community memberDubai• Verified

📋 Protocol Snapshot

Standard Titration
1mg → 12mg weekly
SubQ weekly injection. Gradual dose escalation over 8 weeks.
Maintenance
8-12mg weekly
After reaching target weight. Ongoing for metabolic benefits.

Protocols are for informational purposes only. Always consult a qualified healthcare provider before starting any treatment protocol.

Where to Get It (UAE)

Browse all wellness centers →

Related Treatments

Medical Disclaimer: The information on this page is for educational purposes only and is not intended as medical advice. Kamura Scores reflect a combination of research evidence, community data, and other factors — they are not clinical recommendations. Research citations are provided for reference; always consult the original publications for complete study details. Consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Individual results may vary.